Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dahlberg

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trialB W Dana, S Dahlberg, T P Miller, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Does Perfadex affect outcomes in clinical lung transplantation?Dilip S Nath, Adam R Walter, Adam C Johnson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 28, 2006
Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantationMatthew E Prekker, D S Nath, A R Walker, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 10, 2006
Risk factors for primary graft dysfunction after lung transplantationBryan A Whitson, Dilip S Nath, Adam C Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remissionM S Tallman, K J Kopecky, D Amos, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 1, 1996
A Monte Carlo investigation of artifacts caused by liver uptake in single-photon emission computed tomography perfusion imaging with technetium 99m-labeled agentsM A King, W Xia, D J deVries, et al.
Blood|January 1, 1989
Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapyK K Hussein, S Dahlberg, D Head, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trialP J Stiff, S Dahlberg, S J Forman, et al.
The New England Journal of Medicine|April 8, 1993
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomaR I Fisher, E R Gaynor, S Dahlberg, et al.
Blood|July 1, 1983
Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patientsK M Sullivan, P E Neiman, M E Kadin, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trialB W Dana, S Dahlberg, T P Miller, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Does Perfadex affect outcomes in clinical lung transplantation?Dilip S Nath, Adam R Walter, Adam C Johnson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 28, 2006
Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantationMatthew E Prekker, D S Nath, A R Walker, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 10, 2006
Risk factors for primary graft dysfunction after lung transplantationBryan A Whitson, Dilip S Nath, Adam C Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remissionM S Tallman, K J Kopecky, D Amos, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 1, 1996
A Monte Carlo investigation of artifacts caused by liver uptake in single-photon emission computed tomography perfusion imaging with technetium 99m-labeled agentsM A King, W Xia, D J deVries, et al.
Blood|January 1, 1989
Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapyK K Hussein, S Dahlberg, D Head, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trialP J Stiff, S Dahlberg, S J Forman, et al.
The New England Journal of Medicine|April 8, 1993
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomaR I Fisher, E R Gaynor, S Dahlberg, et al.
Blood|July 1, 1983
Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patientsK M Sullivan, P E Neiman, M E Kadin, et al.
Pageof 11